{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:03Z","timestamp":1791357303439,"version":"4.3.1"},"reference-count":42,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T00:00:00Z","timestamp":1601424000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","award":["1R21MH102724"],"award-info":[{"award-number":["1R21MH102724"]}],"id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0239206","type":"journal-article","created":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T17:28:13Z","timestamp":1601486893000},"page":"e0239206","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":23,"title":["Mortality risk of antipsychotic augmentation for adult depression"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8598-5771","authenticated-orcid":true,"given":"Tobias","family":"Gerhard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T. Scott","family":"Stroup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soko","family":"Setoguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L.","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiqiang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Crystal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Olfson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2020,9,30]]},"reference":[{"issue":"9904","key":"pone.0239206.ref001","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(13)61611-6","article-title":"Global burden of disease attributable to mental and substance use disorders: findings from the Global Burden of Disease Study 2010","volume":"382","author":"HA Whiteford","year":"2013","journal-title":"Lancet"},{"issue":"11","key":"pone.0239206.ref002","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"AJ Rush","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"5","key":"pone.0239206.ref003","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1517\/14656561003614781","article-title":"Pharmacologic approaches to treatment resistant depression: a re-examination for the modern era","volume":"11","author":"NS Philip","year":"2010","journal-title":"Expert Opin Pharmacother"},{"issue":"6","key":"pone.0239206.ref004","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1177\/070674371105600602","article-title":"Antidepressant combinations: widely used, but far from empirically validated","volume":"56","author":"ME Thase","year":"2011","journal-title":"Can J Psychiatry"},{"issue":"7","key":"pone.0239206.ref005","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.euroneuro.2009.01.015","article-title":"Mirtazapine and paroxetine in major depression: a comparison of monotherapy versus their combination from treatment initiation","volume":"19","author":"P Blier","year":"2009","journal-title":"Eur Neuropsychopharmacol"},{"issue":"3","key":"pone.0239206.ref006","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1176\/appi.ajp.2009.09020186","article-title":"Combination of antidepressant medications from treatment initiation for major depressive disorder: a double-blind randomized study","volume":"167","author":"P Blier","year":"2010","journal-title":"Am J Psychiatry"},{"issue":"2","key":"pone.0239206.ref007","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-3223(01)01262-8","article-title":"A double-blind, placebo-controlled study of antidepressant augmentation with mirtazapine","volume":"51","author":"LL Carpenter","year":"2002","journal-title":"Biol Psychiatry"},{"issue":"12","key":"pone.0239206.ref008","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1056\/NEJMoa052964","article-title":"Medication augmentation after the failure of SSRIs for depression","volume":"354","author":"MH Trivedi","year":"2006","journal-title":"N Engl J Med"},{"issue":"7","key":"pone.0239206.ref009","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1586\/14737175.2013.811901","article-title":"Second-generation antipsychotics in the treatment of major depressive disorder: current evidence","volume":"13","author":"C Han","year":"2013","journal-title":"Expert Rev Neurother"},{"key":"pone.0239206.ref010","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.ijlp.2017.10.003","article-title":"Antipsychotic augmentation for major depressive disorder: A review of clinical practice guidelines","volume":"55","author":"P Simons","year":"2017","journal-title":"Int J Law Psychiatry"},{"issue":"3","key":"pone.0239206.ref011","doi-asserted-by":"crossref","first-page":"e1001403","DOI":"10.1371\/journal.pmed.1001403","article-title":"Adjunctive atypical antipsychotic treatment for major depressive disorder: a meta-analysis of depression, quality of life, and safety outcomes","volume":"10","author":"GI Spielmans","year":"2013","journal-title":"PLoS Med"},{"key":"pone.0239206.ref012","article-title":"Antipsychotics should not be used for non-psychotic depression","author":"Therapeutics Initiative.","year":"2015","journal-title":"Therapeutics Letter"},{"issue":"2","key":"pone.0239206.ref013","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nrendo.2011.156","article-title":"Metabolic and cardiovascular adverse effects associated with antipsychotic drugs","volume":"8","author":"M De Hert","year":"2011","journal-title":"Nat Rev Endocrinol"},{"issue":"3","key":"pone.0239206.ref014","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/wps.20579","article-title":"Tardive dyskinesia risk with first- and second-generation antipsychotics in comparative randomized controlled trials: a meta-analysis","volume":"17","author":"M Carbon","year":"2018","journal-title":"World Psychiatry"},{"issue":"15","key":"pone.0239206.ref015","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1001\/jama.294.15.1934","article-title":"Risk of death with atypical antipsychotic drug treatment for dementia: meta-analysis of randomized placebo-controlled trials","volume":"294","author":"LS Schneider","year":"2005","journal-title":"JAMA"},{"issue":"3","key":"pone.0239206.ref016","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa0806994","article-title":"Atypical antipsychotic drugs and the risk of sudden cardiac death","volume":"360","author":"WA Ray","year":"2009","journal-title":"N Engl J Med"},{"issue":"2","key":"pone.0239206.ref017","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/jama.2017.8036","article-title":"Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial","volume":"318","author":"S Mohamed","year":"2017","journal-title":"JAMA"},{"issue":"9","key":"pone.0239206.ref018","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1176\/appi.ajp.2009.09030312","article-title":"Atypical antipsychotic augmentation in major depressive disorder: a meta-analysis of placebo-controlled randomized trials","volume":"166","author":"JC Nelson","year":"2009","journal-title":"Am J Psychiatry"},{"issue":"11","key":"pone.0239206.ref019","doi-asserted-by":"crossref","first-page":"pyv060","DOI":"10.1093\/ijnp\/pyv060","article-title":"Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis","volume":"18","author":"X Zhou","year":"2015","journal-title":"Int J Neuropsychopharmacol"},{"issue":"5","key":"pone.0239206.ref020","doi-asserted-by":"crossref","first-page":"490","DOI":"10.4088\/JCP.13m08675","article-title":"National trends in second-generation antipsychotic augmentation for nonpsychotic depression","volume":"75","author":"T Gerhard","year":"2014","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"pone.0239206.ref021","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.16m10971","article-title":"Antipsychotic Medication Treatment Patterns in Adult Depression","volume":"79","author":"T Gerhard","year":"2018","journal-title":"J Clin Psychiatry"},{"issue":"6","key":"pone.0239206.ref022","doi-asserted-by":"crossref","first-page":"906","DOI":"10.4088\/JCP.08m04450","article-title":"Use of antipsychotics in the treatment of major depressive disorder in the U.S. Department of Veterans Affairs","volume":"70","author":"S Mohamed","year":"2009","journal-title":"J Clin Psychiatry"},{"issue":"2","key":"pone.0239206.ref023","article-title":"Antipsychotic Prescriptions Among Adults With Major Depressive Disorder in Office-Based Outpatient Settings: National Trends From 2006 to 2015","volume":"79","author":"TG Rhee","year":"2018","journal-title":"J Clin Psychiatry"},{"key":"pone.0239206.ref024","unstructured":"Centers for Medicare & Medicaid Services. Medicaid Analytic eXtract (MAX) General Information. Available: https:\/\/www.cms.gov\/MedicaidDataSourcesGenInfo\/07_MAXGeneralInformation.asp Accessed August 10, 2020."},{"issue":"6","key":"pone.0239206.ref025","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cpt.857","article-title":"When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?","volume":"102","author":"JM Franklin","year":"2017","journal-title":"Clinical pharmacology and therapeutics"},{"issue":"2","key":"pone.0239206.ref026","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1097\/00001648-200103000-00021","article-title":"A comparison of the National Death Index and Social Security Administration databases to ascertain vital status","volume":"12","author":"TL Lash","year":"2001","journal-title":"Epidemiology"},{"issue":"3","key":"pone.0239206.ref027","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.biopsych.2009.08.040","article-title":"Antipsychotic dose equivalents and dose-years: a standardized method for comparing exposure to different drugs","volume":"67","author":"NC Andreasen","year":"2010","journal-title":"Biol Psychiatry"},{"issue":"11","key":"pone.0239206.ref028","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1093\/oxfordjournals.aje.a117191","article-title":"Test of the National Death Index and Equifax Nationwide Death Search","volume":"140","author":"JW Rich-Edwards","year":"1994","journal-title":"Am J Epidemiol"},{"key":"pone.0239206.ref029","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1093\/biomet\/70.1.41","article-title":"The central role of the propensity score in observational studies for causal effects","volume":"70","author":"PR Rosenbaum","year":"1983","journal-title":"Biometrika"},{"issue":"5","key":"pone.0239206.ref030","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1161\/CIRCOUTCOMES.113.000359","article-title":"Propensity Score Methods for Confounding Control in Nonexperimental Research","volume":"6","author":"MA Brookhart","year":"2013","journal-title":"Circ-Cardiovasc Qual"},{"issue":"7","key":"pone.0239206.ref031","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1093\/aje\/kwq198","article-title":"Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution\u2014a simulation study","volume":"172","author":"T Sturmer","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"4","key":"pone.0239206.ref032","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1198\/000313004X5824","article-title":"Model selection, confounder control, and marginal structural models: Review and new applications","volume":"58","author":"MM Joffe","year":"2004","journal-title":"Am Stat"},{"issue":"22","key":"pone.0239206.ref033","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain","volume":"315","author":"WA Ray","year":"2016","journal-title":"JAMA"},{"issue":"6","key":"pone.0239206.ref034","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/acps.12878","article-title":"Comparison of guidelines for the treatment of unipolar depression: a focus on pharmacotherapy and neurostimulation","volume":"137","author":"AJ Bayes","year":"2018","journal-title":"Acta Psychiatr Scand"},{"key":"pone.0239206.ref035","volume-title":"Using SAS Software to Perform a Case-Control Match on Propensity Score in an Observational Study","author":"LS Parson","year":"2001"},{"issue":"5","key":"pone.0239206.ref036","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.1200","article-title":"Sensitivity analysis and external adjustment for unmeasured confounders in epidemiologic database studies of therapeutics","volume":"15","author":"S Schneeweiss","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"1","key":"pone.0239206.ref037","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1001\/archinternmed.2009.456","article-title":"Impact of FDA black box advisory on antipsychotic medication use","volume":"170","author":"ER Dorsey","year":"2010","journal-title":"Arch Intern Med"},{"issue":"5","key":"pone.0239206.ref038","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1093\/schbul\/sbn023","article-title":"Secondary effects of antipsychotics: women at greater risk than men","volume":"35","author":"MV Seeman","year":"2009","journal-title":"Schizophr Bull"},{"issue":"1","key":"pone.0239206.ref039","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1192\/bjp.bp.112.122499","article-title":"Comparative mortality risks of antipsychotic medications in community-dwelling older adults","volume":"205","author":"T Gerhard","year":"2014","journal-title":"Br J Psychiatry"},{"key":"pone.0239206.ref040","doi-asserted-by":"crossref","first-page":"e977","DOI":"10.1136\/bmj.e977","article-title":"Differential risk of death in older residents in nursing homes prescribed specific antipsychotic drugs: population based cohort study","volume":"344","author":"KF Huybrechts","year":"2012","journal-title":"BMJ"},{"issue":"5","key":"pone.0239206.ref041","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1001\/jamapsychiatry.2014.3018","article-title":"Antipsychotics, other psychotropics, and the risk of death in patients with dementia: number needed to harm","volume":"72","author":"DT Maust","year":"2015","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"pone.0239206.ref042","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1177\/0891988712436687","article-title":"Mortality risk with the use of atypical antipsychotics in later-life bipolar disorder","volume":"25","author":"S Bhalerao","year":"2012","journal-title":"J Geriatr Psychiatry Neurol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239206","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,30]],"date-time":"2020-09-30T17:29:03Z","timestamp":1601486943000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0239206"}},"subtitle":[],"editor":[{"given":"James M.","family":"Wright","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2020,9,30]]},"references-count":42,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0239206","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9,30]]}}}